NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE
1 – ORGANIZATION
Alliance
Bioenergy Plus, Inc (the “Company”) is a technology company focused on emerging technologies in the renewable energy,
biofuels, and new technologies sectors. In January 2018, the Company’s technology experts developed a new technology system
it calls Cellulose-to-Sugar 2.0 or CTS 2.0, and a patent application was filed. The 100% owned CTS 2.0 is a mechanical/chemical
dry process for converting cellulose material into sugar for use in the biofuels industry. CTS 2.0 can convert any cellulosic
material – like grasses, wood, paper, farm waste, yard waste, forestry products, energy crops like hemp or King Grass, and
the cellulosic portion of municipal solid waste – into sugars and lignin, and subsequently into biofuels and bioplastics.
The CTS 2.0 system produces sugar and chemically unmodified lignin among other by-products. The sugar can then be further converted
into biofuels and the lignin into bioplastics.
The
new technology made it worthwhile to financially restructure the Company through Chapter 11. The Company voluntarily filed for
Chapter 11 on October 22, 2018, in the U.S. Bankruptcy Court in the Southern District of Florida. The Company exited Chapter 11
on September 18, 2019, while keeping all classes, including shareholders, unimpaired. The bankruptcy case was closed on October
25, 2019. Fresh Start accounting is not being applied because existing voting shares immediately before Plan Confirmation were
not less than 50 percent of the voting shares of the emerging entity.
The
Company’s focus is to commercialize its wholly owned CTS 2.0 technology. The Company is currently working with its 4th
generation prototype and anticipates having a 5th generation semi-commercial scale system in 2021.
Plan
of Operation
The
Company is now doing the engineering work to commercialize its 100% owned CTS 2.0 technology.
The
Company has a strategy that includes the following:
|
1)
|
Selling
sugar or ethanol either direct or in combination with joint ventures, mergers, and/or acquisitions of existing businesses
in the renewable energy space;
|
|
2)
|
Selling
low-cost high purity lignin, or using that lignin to produce biodegradable plastics, or making biodegradable bioplastics products
and selling them under our own brand.
|
NOTE
2 – GOING CONCERN
The
accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles,
which contemplate continuation of the Company as a going concern, which assumes the Company will realize its assets and discharge
its liabilities in the normal course of business. The Company has not generated any significant revenue since inception and has
incurred losses since inception. As of December 31, 2020, the Company has a working capital deficiency of $766,555. As of December
31, 2020, the Company has incurred accumulated losses of $46,682,093. On October 22, 2018, the Company filed for Chapter 11 bankruptcy.
On September 18, 2019, the judge confirmed the Company’s Chapter 11 Plan, and on October 25, 2019, the bankruptcy case was
closed. The Company expects to incur significant additional losses and liabilities in connection with its start-up and commercialization
activities. The Company’s ability to continue as a going concern is dependent upon its ability to obtain the necessary financing
to meet its obligations and repay its liabilities when they become due and to generate sufficient revenues from its operations
to pay its operating expenses. These factors, among others, raise substantial doubt about the Company’s ability to continue
as a going concern. These financial statements do not include any adjustments related to the recoverability and classifications
of recorded asset amounts, or amounts and classifications of liabilities that might result from this uncertainty. There are no
assurances that the Company will continue as a going concern.
Management
believes that the Company’s future success is dependent upon its ability to achieve profitable operations, generate cash
from operating activities and obtain additional financing. There is no assurance that the Company will be able to generate sufficient
cash from operations, sell additional shares of stock or borrow additional funds. The Company’s inability to obtain additional
cash could have a material adverse effect on its financial position, results of operations, and its ability to continue in existence.
These financial statements do not include any adjustments that might result from the outcome of this uncertainty
The
Company intends to raise additional capital and continue engineering work and scaling up towards a full-scale commercial size
CTS 2.0 modular unit. At that point, and to minimize dilution to shareholders, the Company will seek project-based financing to
build (or acquire and retrofit) or joint venture with existing ethanol producers to produce cellulosic ethanol and lignin/bioplastics
from its patented CTS 2.0 system. Once the first plant is profitable, the Company intends to grow with additional plants both
in the United States and internationally.
Currently,
the US government gives a D3 RIN to incentivize the production of renewable fuels from cellulosic materials. The value of the
D3 RIN fluctuates, but as of this filing, it is around $2.60 per gallon of ethanol on top of the market price of ethanol.
The
Company believes that its CTS 2.0 process can produce ethanol profitably at the market price, and with the D3 RIN should generate
substantial profits and cash flow in amounts sufficient to cover the Company’s operating expenses and debt service.
Our
business, results of operations, and financial condition may be adversely impacted by the COVID-19 pandemic.
The
COVID-19 pandemic has negatively affected the U.S. and global economies, disrupted global supply chains, resulted in significant
travel and transport restrictions, including mandated closures and orders to “shelter-in-place,” and created significant
disruption of the financial markets. We are closely monitoring the impact of the COVID-19 pandemic on all aspects of our business,
including how it will impact our customers, employees and supply chain. Given the critical nature of the products that we provide,
our office and lab have remained open during the pandemic. The extent to which our operations may be impacted by the COVID-19
pandemic will depend largely on future developments, which are highly uncertain and cannot be accurately predicted. We may experience
additional operating costs due to increased challenges with our workforce (including as a result of illness, absenteeism or government
orders), access to supplies, capital, and fundamental support services (such as shipping and transportation). Even after the COVID-19
pandemic has subsided, we may experience materially adverse impacts to our business due to any resulting economic recession or
depression. Furthermore, the impacts of a potential worsening of global economic conditions and the continued disruptions to and
volatility in the financial markets remain unknown.
NOTE
3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
The
accompanying consolidated financial statements of the Company were prepared in accordance with generally accepted accounting principles
in the U.S. (“U.S. GAAP”) and include the assets, liabilities, revenues and expenses of the Company’s majority-owned
subsidiaries over which the Company exercises control.
Principles
of Consolidation
The
accompanying consolidated financial statements include the accounts of the Company and its subsidiaries, after elimination of
intercompany accounts and transactions. Investments in business entities in which the Company lacks control but has the ability
to exercise significant influence over operating and financial policies are accounted for using the equity method. All material
intercompany transactions and balances were eliminated in consolidation.
Use
of Estimates
The
preparation of financial statements in conformity with accounting principles generally accepted in the United States requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities as of the dates presented and reported amounts of revenues and expenses during the reporting periods presented.
Significant estimates inherent in the preparation of the accompanying Consolidated Financial Statements include estimates of impairment
assessment of identifiable intangible assets and valuation allowance for deferred tax assets. Estimates are based on past experience
and other considerations reasonable under the circumstances. Actual results may differ from these estimates.
Cash
and Cash Equivalents
All
highly liquid investments with maturities of three months or less at the date of purchase are considered to be cash equivalents.
Stock
Compensation
The
Company recognizes the cost of all share-based payments under the relevant authoritative accounting guidance. Share-based payments
include any remuneration paid by the Company in shares of the Company’s common stock or financial instruments that grant
the recipient the right to acquire shares of the Company’s common stock. For share-based payments to employees, which consist
only of awards made under the stock option plan described below, the Company accounts for the payments in accordance with the
provisions of ASC Topic 718, “Stock Compensation” (formerly referred to as SFAS No. 123(R)). Share-based payments
to consultants, service providers and other non-employees are accounted for in accordance with ASC Topic 718, ASC Topic 505, “Equity
Payments to Non-Employees” or other applicable authoritative guidance.
Stock-based
Compensation Valuation Methodology
Stock-based
compensation resulting from the issuance of common stock is calculated by reference to the valuation of the stock on the date
of issuance, the expense being recognized as the compensation is earned. Stock-based compensation expenses related to employee
options and warrants granted to non-employees are recognized as the stock options and warrants are earned. The fair value of the
stock options or warrants granted is estimated at the grant date, using the Black-Scholes option-pricing model, and the expense
is recognized on a straight-line basis over the shorter of the period over which services are to be received or the life of the
option or warrant. The grant date fair value of employee share options and similar instruments is estimated using the Black-Scholes
option-pricing model on the basis of the fair value of the underlying common stock on the measurement date, adjusted for the unique
characteristics of those equity instruments, using the assumptions noted in the table below. The fair value of the common stock
is determined by the then-prevailing closing market price. Expected volatility was based on the historical volatility of the Company’s
closing day market price per share. The expected term of options and warrants was based upon the life of the option, and the risk-free
rate used was based on the U.S. Treasury Daily Yield Curve Rate.
The
stock compensation issued for services during the years ended December 31, 2020, and December 31, 2019, were valued on the date
of issuance. The following assumptions were used in calculations of the Black-Scholes option pricing models for warrant-based
stock compensation issued in the years ended December 31, 2020, and December 31, 2019:
|
|
2/25/19
|
|
|
3/22/19
|
|
|
5/1/19
|
|
|
5/23/19
|
|
|
5/30/19
|
|
|
7/23/19
|
|
|
7/31/19
|
|
Risk-free interest rate
|
|
|
2.48
|
%
|
|
|
2.24
|
%
|
|
|
2.52
|
%
|
|
|
2.31
|
%
|
|
|
2.03
|
%
|
|
|
1.83
|
%
|
|
|
1.84
|
%
|
Expected life
|
|
|
5 years
|
|
|
|
5 years
|
|
|
|
10 years
|
|
|
|
10 years
|
|
|
|
5 years
|
|
|
|
5 years
|
|
|
|
5 years
|
|
Expected dividends
|
|
|
0
|
%
|
|
|
0
|
%
|
|
|
0
|
%
|
|
|
0
|
%
|
|
|
0
|
%
|
|
|
0
|
%
|
|
|
0
|
%
|
Expected volatility
|
|
|
217.76
|
%
|
|
|
221.85
|
%
|
|
|
223.38
|
%
|
|
|
188.70
|
%
|
|
|
224.24
|
%
|
|
|
230.08
|
%
|
|
|
230.30
|
%
|
ALLM common stock fair value
|
|
$
|
0.020
|
|
|
$
|
0.025
|
|
|
$
|
0.040
|
|
|
$
|
0.050
|
|
|
$
|
0.037
|
|
|
$
|
0.050
|
|
|
$
|
0.050
|
|
|
|
1/9/20
|
|
|
2/18/20
|
|
|
5/8/20
|
|
|
11/6/20
|
|
|
11/12/20
|
|
Risk-free interest rate
|
|
|
1.65
|
%
|
|
|
1.39
|
%
|
|
|
0.69
|
%
|
|
|
0.36
|
%
|
|
|
0.40
|
%
|
Expected life
|
|
|
5 years
|
|
|
|
5 years
|
|
|
|
10 years
|
|
|
|
5 years
|
|
|
|
5 years
|
|
Expected dividends
|
|
|
0
|
%
|
|
|
0
|
%
|
|
|
0
|
%
|
|
|
0
|
%
|
|
|
0
|
%
|
Expected volatility
|
|
|
229.32
|
%
|
|
|
228.60
|
%
|
|
|
226.42
|
%
|
|
|
212.00
|
%
|
|
|
213.22
|
%
|
ALLM common stock fair value
|
|
$
|
0.058
|
|
|
$
|
0.065
|
|
|
$
|
0.083
|
|
|
$
|
0.071
|
|
|
$
|
0.080
|
|
Property
and Equipment
Property
and equipment are stated at cost less accumulated depreciation. Depreciation is provided for on a straight-line basis over the
useful lives of the assets, generally 5 to 10 years. Expenditures for additions and improvements are capitalized; repairs and
maintenance are expensed as incurred.
Patent
Capitalization
If
a product is currently under research and development and is not currently approved for market, costs incurred in connection with
patent applications should generally be expensed in the income statement because there is uncertainty as to the future economic
benefit of the asset. Conversely, if a product is approved for market (as is the case of the end product ethanol), or if future
economic benefit is probable, or if an alternative future use is available to the Company, then such patent costs can be capitalized
and amortized over the expected life of the patent(s). Since the Company’s primary end product is sugar converting to ethanol,
which are in wide use, the Company has determined that it is reasonable to capitalize the patent costs associated with its CTS
process.
Research
and Development
The
Company expenses all research and development costs as incurred. For the years ended December 31, 2020, and December 31, 2019,
the amounts charged to research and development expenses were $763,159 and $797,862, respectively.
Revenue
Recognition
The
Company follows FASB ASC 605 “Revenue Recognition” and recognizes revenue when it is realized or realizable and earned.
The Company’s revenues will be derived principally from joint ventures, royalties and eventually corporate owned plants.
However, no sales have occurred through those revenue streams to date. The Company considers revenue realized or realizable and
earned when all of the following criteria are met:
|
1.
|
persuasive
evidence of an arrangement exists;
|
|
2.
|
the
product has been shipped or the services have been rendered to the customer;
|
|
3.
|
the
sales price is fixed or determinable; and,
|
|
4.
|
collectability
is reasonably assured.
|
Convertible
Instruments
The
Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815 “Derivatives
and Hedging Activities”.
Applicable
GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative
financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics
and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks
of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is
not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate
instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.
The
Company accounts for convertible instruments (when we have determined that the embedded conversion options should not be bifurcated
from their host instruments) as follows: The Company records when necessary, discounts to convertible notes for the intrinsic
value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common
stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under
these arrangements are amortized over the term of the related debt to their stated date of redemption.
Accounting
for Derivative Instruments
The
Company issues debentures where the number of shares into which a debenture can be converted is not fixed. For example, when a
debenture converts at a discount to market based on the stock price on the date of conversion. In such instances, the embedded
conversion option of the convertible debentures is bifurcated from the host contract and recorded at their fair value. In accounting
for derivatives, the Company records a liability representing the estimated present value of the conversion feature considering
the historic volatility of the Company’s stock, and a discount representing the imputed interest associated with the beneficial
conversion feature. The discount is then amortized over the life of the debenture and the derivative liability is adjusted periodically
according to stock price fluctuations. At the time of conversion, any remaining derivative liability is charged to additional
paid-in capital. For purposes of determining derivative liability, the Company uses Black-Scholes modeling for computing historic
volatility.
Common
Stock Purchase Warrants and Other Derivative Financial Instruments
The
Company classifies as equity any contracts that require physical settlement or net-share settlement or provide it with a choice
of net-cash settlement or settlement in the Company’s own shares (physical settlement or net-share settlement) provided
that such contracts are indexed to its own stock as defined in ASC 815-40 (“Contracts in Entity’s Own Equity”).
The Company classifies as assets or liabilities any contracts that require net-cash settlement (including a requirement to net
cash settle the contract if an event occurs and if that event is outside the Company’s control) or give the counterparty
a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses the
classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether
a change in classification between assets and liabilities is required.
Non-controlling
interest in consolidated subsidiaries
The
accompanying consolidated financial statements include the accounts of Alliance BioEnergy Plus, Inc. and those subsidiaries that
the Company has the ability to control either through voting rights or means other than voting rights. For these subsidiaries,
the Company records 100% of the revenues, expenses, cash flows, assets and liabilities in its consolidated financial statements.
For subsidiaries that the Company controls but hold less than 100% ownership, a non-controlling interest is recorded in the consolidated
income statement to reflect the non-controlling interest’s share of the net income (loss), and a non-controlling interest
is recorded in the consolidated balance sheet to reflect the non-controlling interest’s share of the net assets of the subsidiary.
As of the date of this filing, the Company has no subsidiaries.
Investments
in non-consolidated affiliates
Investments
in non-consolidated affiliates are accounted for using the equity method or cost basis depending upon the level of ownership and/or
the Company’s ability to exercise significant influence over the operating and financial policies of the investee. When
the equity method is used, investments are recorded at original cost and adjusted periodically to recognize the Company’s
proportionate share of the investees’ net income or losses after the date of investment. When net losses from an investment
are accounted for under the equity method exceed its carrying amount, the investment balance is reduced to zero and additional
losses are not provided for. The Company resumes accounting for the investment under the equity method if the entity subsequently
reports net income and the Company’s share of that net income exceeds the share of net losses not recognized during the
period the equity method was suspended. Investments are written down only when there is clear evidence that a decline in value
that is other than temporary has occurred. The Company monitors its investment for impairment at least annually and makes appropriate
reductions in the carrying value if it determines that an impairment charge is required based on qualitative and quantitative
information. As of the date of this filing, the Company has no investments in non-consolidated affiliates.
Impairment
of Long Lived Assets
Long-lived
assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group
may not be recoverable. If events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable,
the Company compares the carrying amount of the asset group to future undiscounted net cash flows, excluding interest costs, expected
to be generated by the asset group and their ultimate disposition. If the sum of the undiscounted cash flows is less than the
carrying value, the impairment to be recognized is measured by the amount by which the carrying amount of the asset group exceeds
the fair value of the asset group. Assets to be disposed of are reported at the lower of the carrying amount or fair value, less
costs to sell.
Income
Taxes
The
Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, “Income Taxes.”
Under this method, income tax expense is recognized for the amount of: (i) taxes payable or refundable for the current year and
(ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s
financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply
to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the
enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of the available
positive and negative evidence, it is more likely than not some portion or all of the deferred tax assets will not be realized.
ASC
Topic 740.10.30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements
and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a
tax position taken or expected to be taken in a tax return. ASC Topic 740.10.40 provides guidance on derecognition, classification,
interest and penalties, accounting in interim periods, disclosure, and transition. The Company has no material uncertain tax positions
for any of the reporting periods presented.
Profit
(Loss) per Common Share:
Basic
profit (loss) per share amounts have been calculated using the weighted-average number of common shares outstanding during each
reporting period. Diluted loss per share has been calculated using the weighted-average number of common shares plus the potentially
dilutive effect of securities such as outstanding options and warrants. The computation of potential common shares has been performed
using the treasury stock method. The warrants and options are antidilutive for all periods presented. When net loss is reported,
diluted and basic net loss per share amounts are the same as the impact of potential common shares is antidilutive.
Fair
Value Measurements
The
Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures”, which defines fair value
as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair
value measurements.
The
estimated fair value of certain financial instruments, payables to related parties, and accounts payable and accrued expenses
are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments.
ASC
820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price)
in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants
on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable
inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may
be used to measure fair value:
Level
1 — quoted prices in active markets for identical assets or liabilities
Level
2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable
Level
3 — inputs that are unobservable (for example cash flow modeling inputs based on assumptions)
For
the years ended December 31, 2020, and December 31, 2019, the Company recognized a gain of $0 and a gain of $656,533, respectively,
on the change in fair value of its derivative liabilities. At December 31, 2020, the Company did not identify any assets or liabilities
that are required to be presented on the balance sheet at fair value in accordance with ASC 825-10.
Recent
Accounting Pronouncements
From
time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies
that may have an impact on the Company’s accounting and reporting. The Company believes that such recently issued accounting
pronouncements and other authoritative guidance for which the effective date is in the future either will not have an impact on
its accounting or reporting or that such impact will not be material to its financial position, results of operations, and cash
flows when implemented.
NOTE
4 – ASSETS
Patents
The
Company has applied for two patents on its technology, and has also applied for international patents. The Company has capitalized
the legal and filing fees in the amount of $138,016.
NOTE
5 – DEBT
Details
of each debt, including those that have been paid off or renegotiated during 2018 or 2019, are indicated below.
Convertible
Debentures Related Party
On
March 12, 2019, the Company entered into a convertible promissory note with Edmund J Burke for a total of $25,000. The note is
due on March 12, 2021, and carries no interest. To the extent unpaid five years after September 18, 2019, it is discharged. At
the option of the noteholder, the note is convertible into common stock at $0.025/share. On January 22, 2021, Edmund Burke elected
to convert this Note into common stock.
On
March 12, 2019, the Company entered into a convertible promissory note with Chris Jemapete for a total of $25,000. The note is
due on March 12, 2021, and carries no interest. To the extent unpaid five years after September 18, 2019, it is discharged. At
the option of the noteholder, the note is convertible into common stock at $0.025/share. On August 5, 2020, Chris Jemapete elected
to convert the note into common stock.
On
March 12, 2019, the Company entered into a convertible promissory note with AES Capital Partners, LP, for a total of $50,000.
The note is due on March 12, 2021, and bears 15% interest. To the extent unpaid five years after September 18, 2019, it is discharged.
At the option of the noteholder, the note is convertible into common stock at $0.025/share. Upon conversion, all interest shall
be forgiven. On January 22, 2021, AES Capital Partners, LP, elected to convert this Note into common stock.
Paycheck
Protection Program SBA Loan
In
May 2020, the Company received a loan in the amount of $66,330 under the Payroll Protection Program (“PPP Loan”).
The loan accrues interest at a rate of 1% and has an original maturity date of two years which can be extended to five years by
mutual agreement of the Company and SBA. The PPP loan contains customary events of default relating to, among other things, payment
defaults and breaches of representations and warranties.
Under
the terms of the loan, a portion or all of the loan is forgivable to the extent the loan proceeds are used to fund qualifying
payroll, rent and utilities during a designated twenty-four week period. Payments are deferred until the SBA determines the amount
to be forgiven. The Company has utilized the proceeds of the PPP loan in a manner which will enable qualification as a forgivable
loan. However, no assurance can be provided that all or any portion of the PPP loan will be forgiven. The balance on this PPP
loan was $66,330 as of December 31, 2020 and has been classified as a long-term liability in notes payable.
Notes
Payable — Chapter 11 Settlement
On
July 18, 2018, the Company’s former Controller Dennis Lenaburg sued the Company for $2,694,577 dollars plus stock warrants
in the Circuit Court of the 15th Judicial Circuit in Palm Beach County, Florida. That lawsuit was moved to the Bankruptcy
Court when the Company entered Chapter 11 on October 22, 2018. The Company filed a Complaint against Lenaburg on November 16,
2018, in the bankruptcy court in the Southern District of Florida. The bankruptcy judge ordered mediation, and a settlement was
reached that paid Lenaburg $13,650 upon Plan Confirmation and a $50,000 claim payable out of post-confirmation net profits over
3 years, plus 1.5 million common stock warrants with a strike price of $0.30/share and a ten year expiration period. The $50,000
is due on September 18, 2022.
Notes
Payable – Related Parties
In
July 2016, the Company issued six (6) short-term notes payable to related parties in conjunction with the Company’s acquisition
of the remaining 49% of AMG Energy Group. These notes had a value of $2,002,126 and accrued interest at a rate of six percent
(6%) per annum. As of December 31, 2018, and December 31, 2017, the total interest accrued on the notes was $278,794.68 and $176,460
respectively. All of the notes were due on August 4, 2017 and then were in default. However, the notes were held by related parties
with the understanding that the notes were not to be paid until the Company begins generating profit. The Company renegotiated
some of these notes during its Chapter 11 proceedings, whereas others failed to submit a claim and were discharged upon the Court’s
Confirmation Order approving the Company’s Chapter 11 Plan on September 18, 2019. The renegotiated amounts, as per the Plan
Confirmation are all to be paid from 50% of the future net profits and discharged to the extent unpaid five years after the Plan
effective date of September 18, 2019. These amount are 1) Mark Koch $240,990 plus 6% interest on any portion not repaid within
12 months of the Company’s first reported quarterly net profit; 2) Animated Family Films $579,942 out of the Company’s
net profits plus 6% interest; 3) Steven Dunkle, CTWC, & Wellington Asset Holdings $1.5 million plus 6% interest once there
is positive quarterly EBITDA from the first plant of Company, or, at its option, may convert that into an equity investment in
the first plant of the Company, measured by a percentage of the total cost to build, subject to a minimum equity interest of 1.25%
in said plant.
On
February 28, 2018, the Company entered into a short-term loan with Steven Sadaka, with a principal balance of $100,000 due and
payable on May 1, 2018. The note does not accrue interest, however the Company provided 2,000,000 inducement shares to secure
the note. These inducement shares were valued at $84,000 and are being amortized over the life of the note. The note’s maturity
date was extended to 7/1/2018. If the note is not repaid at maturity, then an additional 5,000,000 shares of common stock will
be due. The note was renegotiated during the Company’s Chapter 11 proceedings, and as per the Plan Confirmation, it is agreed
that $100,000 is to be paid out of future gross revenues to satisfy this note in full, with no additional shares to be issued.
On
May 15, 2018, the Company entered into a short term loan with Christopher Jemapete, with a principal balance of $50,000 due and
payable on May 16, 2019. The note carried an interest rate of 5% plus the company issued 1,250,000 inducement shares to secure
the note as well as 1,000,000 warrants with a $0.10 strike price and with a 5-year expiration. These inducement shares were valued
at $36,250 and are being amortized over the life of the note; the warrants had a value of $24,449. On August 25, 2018, this note
was restructured to remove the warrants. As of June 30, 2018 accrued interest on this note is $315. The note was renegotiated
during the Company’s Chapter 11 proceedings, and as per the Plan Confirmation, it is agreed that $50,315.07 is to be paid
out of future gross revenues.
On
May 15, 2018, the Company entered into a short term loan with Pamela Jemapete, with a principal balance of $50,000 due and payable
on May 16, 2019. The note carried an interest rate of 5% plus the company issued 1,250,000 inducement shares to secure the note
as well as 1,000,000 warrants with a $0.10 strike price and with a 5-year expiration. These inducement shares were valued at $36,250
and are being amortized over the life of the note; the warrants had a value of $24,449. On August 25, 2018, this note was restructured
to remove the warrants. As of June 30, 2018 accrued interest on this note is $315. The note was renegotiated during the Company’s
Chapter 11 proceedings, and as per the Plan Confirmation, it is agreed that $50,315.07 is to be paid out of future gross revenues.
Notes
Payable – Other
In
July 2016, the Company issued a short-term note payable to a third party in conjunction with the Company’s acquisition of
the remaining 49% of AMG Energy Group. The note had a principal balance of $96,570 and accrued interest at a rate of six percent
(6%) per annum. As of December 31, 2018, and December 31, 2017, the total interest accrued on the note was $14,382.2 and $8,588
respectively. The note was due on August 4, 2017 and was then in default. The Company renegotiated this note during its Chapter
11 proceedings, and as per the Plan Confirmation, now the $96,570 is to be paid with no interest out of the same 50% of the future
net profits of the Company as the notes mentioned above, if any, or discharged to the extent unpaid five years after September
18, 2019.
In
November 2017, the Company entered into a convertible debenture with Lucas Hoppel, with a principal balance of $143,000 due and
payable on May 30, 2018. The note carries an 8% one-time interest charge, a $43,000 original issue discount and a 35% conversion
discount to the lowest trade price in the prior twenty-five trading days, after 180 days, in whole or in part at the option of
the holder. In addition, the Company provided 500,000 inducement shares to secure the note, and may have to provide additional
shares on the note’s 6-month anniversary if the Company’s share price declines. These inducement shares were valued
at $39,500 and were amortized over the life of the note. The note can be repaid, without prepayment penalties, within the first
90 days. Thereafter, the note will incur a 120% prepayment penalty of the then outstanding principal and interest due. In May
2018, the company made two principal payments totaling $40,000. The note went into default on June 1, 2018 and incurred a 40%
penalty of the outstanding balance immediately prior to the default event. On August 30, 2018, Hoppel sued the Company in Superior
Court of the State of California County of San Diego Central District. That case was staid on October 22, 2018 when the Company
filed for Chapter 11 protection in the US Bankruptcy Court in the Southern District of Florida. Negotiations took place and a
settlement was reached on this note and a subsequent note, and confirmed as part of the Plan Confirmation Order, that Hoppel would
be paid a total of $100,000 out of 5% of the future gross revenue of the Company.
In
February 2018, the Company entered into a convertible debenture with Lucas Hoppel, with a principal balance of $165,000 due and
payable on September 21, 2018. The note carries an 8% one-time interest charge, a $15,000 original issue discount and a 40% conversion
discount to the lowest trade price in the prior twenty-five trading days, after 180 days, in whole or in part at the option of
the holder. In addition, the Company provided 500,000 inducement shares to secure the note. These inducement shares were valued
at $14,500, and were amortized over the life of the note. The note can be repaid, without prepayment penalties, within the first
90 days. Thereafter, the note will incur a 120% prepayment penalty of the then outstanding principal and interest due. The Note
went into default on June 1, 2018, through a cross default provision with another Note to Hoppel, and incurred a 40% penalty of
the outstanding balance immediately prior to the default event. On August 30, 2018, Hoppel sued the Company in Superior Court
of the State of California County of San Diego Central District. That case was staid on October 22, 2018 when the Company filed
for Chapter 11 protection in the US Bankruptcy Court in the Southern District of Florida. Negotiations took place and a settlement
was reached on this note and a prior note, and confirmed as part of the Plan Confirmation Order, that Hoppel would be paid a total
of $100,000 out of 5% of the future gross revenue of the Company to settle both notes.
On
March 27, 2019, the Company entered into an agreement with Partiz and Company, P.A. such that its debt will be reduced from $32,000
to $20,000 payable out of future gross revenues, upon the bankruptcy court’s acceptance of the Company’s plan of reorganization.
The Plan was confirmed by the Court on September 18, 2019.
Convertible
Debentures – Related Parties
On
November 8, 2018, the Company entered into a convertible promissory note with Edmund J Burke for a total of $175,000. There is
no interest, and it is payable out of 20% of the net profits of Company. The note is convertible into common stock at $0.05/share.
Upon conversion, Burke shall receive an additional 4,450,148 warrants at a strike price of $0.005/share that expire on November
8, 2023. In addition, 4,450,148 shares of Burke’s common stock was cancelled. On January 22, 2021, Edmund Burke elected
to convert this Note into common stock.
On
November 8, 2018, the Company entered into a convertible promissory note with Steven Sadaka for a total of $24,000. There is no
interest, and it is payable out of 2.5% of the net profits of Company. The note is convertible into common stock at $0.05/share.
Upon conversion, Sadaka shall receive an additional 1,000,000 warrants at a strike price of $0.005/share that expire on November
8, 2023. In addition, 1,000,000 shares of Sadaka’s common stock was cancelled. On January 15, 2021, Steven Sadaka elected
to convert this Note into common stock.
On
November 8, 2018, the Company entered into a convertible promissory note with Annie Bindler for a total of $2,500. There is no
interest, and it is payable out of 0.5% of the net profits of Company. The note is convertible into common stock at $0.05/share.
Upon conversion, Annie Bindler shall receive an additional 100,000 warrants at a strike price of $0.005/share that expire on November
8, 2023. In addition, 100,000 shares of Annie Bindler’s common stock was cancelled. On January 13, 2021, Annie Bindler elected
to convert this Note into common stock.
On
November 8, 2018, the Company entered into a convertible promissory note with Zac Bindler for a total of $2,500. There is no interest,
and it is payable out of 0.5% of the net profits of Company. The note is convertible into common stock at $0.05/share. Upon conversion,
Zac Bindler shall receive an additional 100,000 warrants at a strike price of $0.005/share that expire on November 8, 2023. In
addition, 100,000 shares of Zac Bindler’s common stock was cancelled. On January 13, 2021, Zac Bindler elected to convert
this Note into common stock.
A
summary of all debts indicated in the Notes above is as follows:
Notes Payable
|
|
December 31, 2020
|
|
|
December 31, 2019
|
|
Short Term Notes Payable - Related Party
|
|
$
|
-
|
|
|
$
|
|
|
Short Term Convertible Debentures Related Party
|
|
$
|
75,000
|
|
|
$
|
|
|
Long Term Chapter 11 Settlement
|
|
$
|
50,000
|
|
|
$
|
50,000
|
|
Long Term Paycheck Protection Program SBA loan
|
|
$
|
66,330
|
|
|
$
|
|
|
Long Term Notes Payable from future revenue — Related Party
|
|
$
|
1,700,630
|
|
|
$
|
1,700,630
|
|
Long Term Notes Payable from future revenue — Other
|
|
$
|
120,000
|
|
|
$
|
120,000
|
|
Long Term Note Payable from future profits — Related Party
|
|
$
|
820,932
|
|
|
$
|
820,932
|
|
Long Term Note Payable from future profits — Other
|
|
$
|
96,570
|
|
|
$
|
96,570
|
|
Long Term Convertible Debentures — Related Party
|
|
$
|
204,000
|
|
|
$
|
304,000
|
|
TOTAL NOTES
|
|
$
|
3,133,462
|
|
|
$
|
3,092,132
|
|
$100,000
of the amount listed under Long Term Convertible Debentures in the summary chart for 2019 were short term as of the end of 2020.
Of
the $3,133,462 due as of December 31, 2020, $1,820,630 is due out of future revenue and $917,502 is due out of future profits,
totaling $2,738,132. $2,417,502 of that debt will be discharged if not paid by September 18, 2024, which is 5 years after the
Company exited Chapter 11. $66,330 may be forgiven by the SBA. The remaining debt that would not be discharged or forgiven, and
which has not converted as of the date of this filing, is $170,000, consisting of $120,000 due out of future revenue to other,
and a $50,000 Chapter 11 settlement.
NOTE
6 – STOCKHOLDERS’ EQUITY
The
total number of shares of capital stock, which the Company has authority to issue, is 510 million, 500 million of which are designated
as common stock at $0.001 par value (the “Common Stock”) and 10 million of which are designated as preferred stock
par value $0.001 (the “Preferred Stock”). As of December 31, 2020, the Company had 241,721,947 shares of Common Stock
issued and outstanding and no shares of Preferred Stock were issued. Holders of shares of Common stock shall be entitled to cast
one vote for each share held at all stockholders’ meetings for all purposes, including the election of directors. The Common
Stock does not have cumulative voting rights. No holder of shares of stock of any class shall be entitled as a matter of right
to subscribe for or purchase or receive any part of any new or additional issue of shares of stock of any class, or of securities
convertible into shares of stock of any class, whether now hereafter authorized or whether issued for money, for consideration
other than money, or by way of dividend. The Company has yet to designate any rights, preferences and privileges for any of its
authorized Preferred Stock.
In
the year ended December 31, 2019, the Company issued an aggregate of 1,936,450 shares of its common stock for services valued
at $68,472.
In
the year ended December 31, 2019, the Company issued an aggregate of 2,425,000 warrants for services. Using a Black-Scholes asset-pricing
model, these warrants were valued at $120,084. These warrant agreements have terms of five years with exercise prices of $0.05
per share.
In
the year ended December 31, 2019, 500,000 warrants expired.
In
the year ended December 31, 2019, the Company issued an aggregate of 57,800,000 shares of common stock to management and directors.
These were valued at $289,000.
In
the year ended December 31, 2019, the Company issued an aggregate of 19,436,385 shares of common stock for cash through private
placements for $934,819.
In
the year ended December 31, 2019, the Company issued an aggregate of 100,000 shares of common stock for debt. These were valued
at $5000.
In
the year ended December 31, 2019, the Company issued an aggregate of 8,900,000 options under the employee stock option plan. These
were valued at $220,299. The Company also rescinded 49,275,157 options issued under the employee stock option plan.
In
the year ended December 31, 2019, the Company issued an aggregate of 8,500,000 warrants as per Chapter 11 Settlement Agreements.
Using a Black-Scholes asset-pricing model, these totaled to $212,853.
In
the year ended December 31, 2020, the company issued an aggregate of 733,130 shares of its common stock for services, valued at
$37,500.
In
the year ended December 31, 2020, the Company did not issue any warrants for services.
In
the year ended December 31, 2020, 6,639,344 warrants were exercised at an average price of 5.3 cents for total proceeds of $350,000.
In
the year ended December 31, 2020, 9,155,656 warrants and options expired.
In
the year ended December 31, 2020, 500,000 employee stock options were exercised using the cashless exercise provision to obtain
277,778 shares.
In
the year ended December 31, 2020, the Company issued 13,558,462 common shares for cash of $887,380.
In
the year ended December 31, 2020, $25,000 of convertible notes issued during Chapter 11 to a related party converted into 1,000,000
shares of common stock.
In
the year ended December 31, 2020, the Company issued options under its Employee & Directors Stock Option Plan to purchase
an aggregate of 11,000,000 shares of common stock for a period of five to ten years at an exercise price ranging from $0.042 to
$0.10. Using a Black-Scholes asset-pricing model, these agreements were valued at $876,291. An additional 10,550,000 unvested
options were issued.
Share-Based
Awards
Stock
option activity under the 2012 ESOP for the year ending December 31, 2020, is as follows:
|
|
Option Shares Outstanding
|
|
|
Weighted Average Exercise Price
|
|
|
Weighted Average Remaining Contractual Term (years)
|
|
|
Aggregate Intrinsic Value ($0’s)
|
|
Outstanding as of December 31, 2019
|
|
|
5,807,099
|
|
|
$
|
0.08
|
|
|
|
6.43
|
|
|
$
|
445,815
|
|
Awarded
|
|
|
21,550,000
|
|
|
$
|
0.10
|
|
|
|
9.17
|
|
|
$
|
2,108,000
|
|
Exercised
|
|
|
500,000
|
|
|
$
|
0.05
|
|
|
|
-
|
|
|
$
|
25,000
|
|
Expired
|
|
|
2,900,000
|
|
|
$
|
0.09
|
|
|
|
-
|
|
|
$
|
257,250
|
|
Outstanding as of December 31, 2020
|
|
|
23,957,099
|
|
|
$
|
0.09
|
|
|
|
8.64
|
|
|
$
|
2,271,565
|
|
Vested as of December 31, 2020
|
|
|
12,707,099
|
|
|
$
|
0.09
|
|
|
|
8.22
|
|
|
$
|
1,186,565
|
|
Warrant
activity for the year ending December 31, 2020, is as follows:
|
|
Warrants Outstanding
|
|
|
Weighted Average Exercise Price
|
|
|
Weighted Average Remaining Contractual Term (years)
|
|
|
Aggregate Intrinsic Value ($0’s)
|
|
Outstanding as of December 31, 2019
|
|
|
42,002,390
|
|
|
$
|
0.28
|
|
|
|
3.16
|
|
|
$
|
11,693,720
|
|
Issued
|
|
|
19,533,333
|
|
|
$
|
0.11
|
|
|
|
0.53
|
|
|
$
|
2,180,000
|
|
Exercised
|
|
|
6,639,344
|
|
|
$
|
0.05
|
|
|
|
-
|
|
|
$
|
350,000
|
|
Expired
|
|
|
6,255,656
|
|
|
$
|
0.09
|
|
|
|
-
|
|
|
$
|
554,920
|
|
Outstanding as of December 31, 2020
|
|
|
48,640,723
|
|
|
$
|
0.23
|
|
|
|
2.09
|
|
|
$
|
11,178,470
|
|
Vested as of December 31, 2020
|
|
|
48,640,723
|
|
|
$
|
0.23
|
|
|
|
2.09
|
|
|
$
|
11,178,470
|
|
NOTE
7 – INCOME TAXES
The
reconciliation of income tax benefit at the U.S. statutory rate of 21% for years ending December 31, 2020, and 2019, to the Company’s
effective tax rate, is as follows:
|
|
December 31, 2020
|
|
|
December 31, 2019
|
|
Statutory federal income tax rate
|
|
|
-21
|
%
|
|
|
-21
|
%
|
State income tax, net of federal benefits
|
|
|
-4.46
|
%
|
|
|
-4.46
|
%
|
Valuation Allowance
|
|
|
25.46
|
%
|
|
|
25.46
|
%
|
Income tax provision (benefit)
|
|
|
0
|
%
|
|
|
0
|
%
|
The
provisional (benefit) for income tax is summarized as follows:
|
|
December 31, 2020
|
|
|
December 31, 2019
|
|
Federal
|
|
|
|
|
|
|
|
|
Current
|
|
|
-
|
|
|
|
-
|
|
Deferred
|
|
$
|
(458,037
|
)
|
|
$
|
211,072
|
|
State
|
|
|
|
|
|
|
|
|
Current
|
|
|
|
|
|
|
-
|
|
Deferred
|
|
$
|
(97,278
|
)
|
|
$
|
44,828
|
|
Change in valuation allowance
|
|
|
588,904
|
|
|
|
(255,900
|
)
|
Income tax provision (benefit)
|
|
|
-
|
|
|
|
-
|
|
The
tax effects of temporary differences that give rise to the Company’s net deferred tax liability as of December 31, 2020
and 2019 are as follows:
|
|
Years Ended
|
|
|
|
December 31, 2020
|
|
|
December 31, 2019
|
|
Deferred tax asset
|
|
|
|
|
|
|
|
|
Net operating loss carryovers
|
|
$
|
10,662,231
|
|
|
$
|
10,106,916
|
|
Total deferred tax assets
|
|
|
10,662,231
|
|
|
|
10,106,916
|
|
Valuation Allowance
|
|
|
(10,662,231
|
)
|
|
|
(10,106,916
|
)
|
Deferred tax asset, net of allowance
|
|
$
|
-
|
|
|
$
|
-
|
|
As
of December 31, 2020, and 2019, the Company had approximately $41,878,363, and $39,697,236 of Federal net operating loss carryovers
(“NOLs”) to offset taxable income, if any, in future years which begin to expire in 2033. Utilization of the NOLs
may be subject to limitation under the Internal Revenue Code Section 382 should there be a greater than 50% ownership change as
determined under regulations.
In
assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or
all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation
of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled
reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Based
on the assessment, management has established a full valuation allowance against the entire deferred tax asset relating to NOLs
for every period because it is more likely than not that all of the deferred tax asset will not be realized.
On
December 22, 2017, the Tax Cuts and Jobs Act of 2017 (the “Tax Act”) was signed into law making significant changes
to the Internal Revenue Code. Changes include, but are not limited to, a federal corporate tax rate decrease from 35% to 21% for
tax years beginning after December 31, 2017, the transition of U.S international taxation from a worldwide tax system to a territorial
system, and a one-time transition tax on the mandatory deemed repatriation of foreign earnings. The Company has estimated its
provision for income taxes in accordance with the Tax Act and guidance available.
The
Company files U.S. Federal and Florida tax returns that are subject to audit by tax authorities beginning with the year ended
December 31, 2012. The Company’s policy is to classify assessments, if any, for tax and related interest and penalties as
tax expense.
NOTE
8 - COMMITMENTS AND CONTINGENCIES
Litigation
The
Company is subject, from time to time, to litigation, claims and suits arising in the ordinary course of business.
On
June 21, 2018, Power Up Lending Group Ltd., sued both the Company and four of its managers, ex-managers, and directors of the
Company in the United States District Court for the Eastern District of New York. The case was dropped against the Company when
Power Up failed to submit a claim in the Company’s Chapter 11 case by the Court Ordered deadline. The claim was discharged
by the bankruptcy court upon Plan Confirmation on September 18, 2019. Power Up has continued a tort case against the individuals.
The D&O insurance has agreed to cover the CEO Ben Slager, CFO Anthony Santelli, as well as ex-Controller Dennis Lenaburg,
in this case. Management believes the Complaint is frivolous and has filed a motion to dismiss which is pending before the Court
as of the date of this filing.
Leases
The
Company consolidated its premises into one location on November 1, 2019, and currently leases office and laboratory space in Palm
Beach Gardens, FL, that is classified as operating lease right-of-use (“ROU”) assets and operating lease liabilities
in the Company’s consolidated balance sheet. ROU assets and lease liabilities are recognized based on the present value
of the future minimum lease payments over the lease term at the commencement date for leases exceeding 12 months. The lease period
is for twenty-four (24) months from November 1, 2019, to October 31, 2021. This had been extended for one year until October
31, 2022. Annual rent commences at $84,100 per annum and increases 3% per year. Tenant is also required to cover operating costs
that are estimated at $3,084 per month. Operating lease expense is recognized on a straight-line basis over the lease term and
is included in General & Administrative expenses.
ASC
842 was effective for us beginning January 1, 2019. The adoption had a material impact on our consolidated balance sheets, but
did not have a material impact on our consolidated income statements. The most significant impact was the recognition of ROU assets
and lease liabilities for operating leases.
Rent
expense for the years ending December 31, 2020, and 2019, were $78,825 and $62,239, respectively.
The
Company recognized the following related to leases in its Consolidated Balance Sheet:
YEAR ENDED
|
|
December 31, 2020
|
|
|
December 31, 2019
|
|
Right of Use Lease Liabilities
|
|
|
|
|
|
|
|
|
Current portion
|
|
|
80,078
|
|
|
|
77,746
|
|
Long-term portion
|
|
|
72,346
|
|
|
|
70,240
|
|
TOTAL
|
|
|
152,424
|
|
|
|
147,986
|
|
As
of December 31, 2020, the total future minimum lease payments in respect of leased premises are as follows:
YEAR ENDED
|
|
MINIMUM DUE
|
|
2021
|
|
|
87,056
|
|
2022
|
|
|
74,351
|
|
2023
|
|
|
0
|
|
|
|
|
|
|
TOTAL
|
|
$
|
161,407
|
|
NOTE
9 – RELATED PARTY TRANSACTIONS
Related
Transactions
The
Company follows FASB ASC subtopic 850-10, Related Party Disclosures, for the identification of related parties and disclosure
of related party transactions. Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for
which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value
Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts
for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management;
d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party
controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting
parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence
the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties
and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully
pursuing its own separate interests.
|
1)
|
Short-term
notes payable, convertible notes, and contingent liabilities issued to related parties are described in NOTE 5.
|
|
2)
|
A
board resolution was passed on February 13, 2020, that pledged the pending patents to secure the back pay claims of Ben Slager,
CEO, Anthony Santelli, CFO, and Charles Sills, Director. This was done to ensure the continued involvement of management to
build the Company while they continue to receive less than full salaries.
|
The
officers and directors for the Company are involved in other business activities and may, in the future, become involved in other
business opportunities. If a specific business opportunity becomes available, such persons may face a conflict in selecting between
the Company and their other business interest. The Company has not formulated a policy for the resolution of such conflicts.
NOTE
10 – SUBSEQUENT EVENTS
The
Company has evaluated subsequent events through the date the financial statements were available to be issued. Based on this evaluation,
the Company has identified the following subsequent events:
Subsequent
to December 31, 2020, the Company issued 123,000 shares of common stock for services valued at $21,930, and 100,000 shares of
common stock for future services valued at $25,000.
Subsequent
to December 31, 2020, the Company issued 1,166,667 warrants for services to acquire stock at 15 cents per share. Using a Black-Scholes
pricing model, these were valued at $72,090.
Subsequent
to December 31, 2020, the Company raised $1,935,750 through its private offerings and issued 9,243,332 shares.
Subsequent
to December 31, 2020, 13,455,009 warrants were executed at an average price of $0.10 per share for total proceeds of $1,302,817.
Subsequent
to December 31, 2020, 9,913,334 warrants expired.
Subsequent
to December 31, 2020, 200,000 employee stock options were exercised using the cashless exercise provision to obtain 177,778 shares.
Subsequent
to December 31, 2020, 350,000 employee stock options were exercised.
Subsequent
to December 31, 2020, no employee stock options expired.
Subsequent
to December 31, 2020, the Company issued 20,530,000 employee stock options, of which 10,000 are vested. No additional options
vested.
Subsequent
to December 31, 2020, 10,000 employee stock options vested.
Subsequent
to December 31, 2020, $274,000 of convertible notes issued during Chapter 11 to related parties and $5,000 of convertible notes
issued during Chapter 11 to unrelated parties, converted into 6,980,000 and 100,000 shares of common stock, respectively.